These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 29234842)

  • 1. [Patients with a wearable cardioverter-defibrillator (WCD) : Prescription, function and rehabilitation support].
    Schlitt A; Guha M; Noutsias M; Klein HH; Klein HU
    Herz; 2019 Aug; 44(5):379-389. PubMed ID: 29234842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator.
    Klein HU; Goldenberg I; Moss AJ
    Eur Heart J; 2013 Aug; 34(29):2230-42. PubMed ID: 23729691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of wearable cardioverter-defibrillator use on long-term decision for implantation of a cardioverter-defibrillator in a semirural acute care hospital.
    Sinha AM; Bense J; Hohenforst-Schmidt W
    J Interv Card Electrophysiol; 2021 Nov; 62(2):401-407. PubMed ID: 33200285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Wearable defibrillator : Current evidence].
    Duncker D; Veltmann C
    Herzschrittmacherther Elektrophysiol; 2018 Dec; 29(4):362-368. PubMed ID: 30357452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapy optimization in patients with heart failure: the role of the wearable cardioverter-defibrillator in a real-world setting.
    Röger S; Rosenkaimer SL; Hohneck A; Lang S; El-Battrawy I; Rudic B; Tülümen E; Stach K; Kuschyk J; Akin I; Borggrefe M
    BMC Cardiovasc Disord; 2018 Mar; 18(1):52. PubMed ID: 29544442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effective treatment of electrical storm by a wearable cardioverter defibrillator in a patient with severely impaired left ventricular function after myocardial infarction: a case report.
    Andresen H; Sasko B; Patschan D; Pagonas N; Ritter O
    J Med Case Rep; 2021 May; 15(1):243. PubMed ID: 33993888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of the wearable cardioverter defibrillator in high-risk cardiac patients: data from the Prospective Registry of Patients Using the Wearable Cardioverter Defibrillator (WEARIT-II Registry).
    Kutyifa V; Moss AJ; Klein H; Biton Y; McNitt S; MacKecknie B; Zareba W; Goldenberg I
    Circulation; 2015 Oct; 132(17):1613-9. PubMed ID: 26316618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wearable cardioverter defibrillator after cardiac surgery: Analysis of real-life data from patients at transient risk of sudden cardiac death.
    Elbayomi M; Weyand M; Seitz T; Harig F
    Ann Noninvasive Electrocardiol; 2023 Mar; 28(2):e13048. PubMed ID: 36723848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experience with the wearable cardioverter-defibrillator in older patients: Results from the Prospective Registry of Patients Using the Wearable Cardioverter-Defibrillator.
    Daimee UA; Vermilye K; Moss AJ; Goldenberg I; Klein HU; McNitt S; Zareba W; Kutyifa V
    Heart Rhythm; 2018 Sep; 15(9):1379-1386. PubMed ID: 29678779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The Wearable Cardioverter-Defibrillator (WCD)].
    Helms TM; Müller A; Schwab JO; Bänsch D; Karle C; Klingenheben T; Zugck C; Perings C
    Herzschrittmacherther Elektrophysiol; 2015 Jun; 26(2):129-33. PubMed ID: 25939989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Avoiding Untimely Implantable Cardioverter/Defibrillator Implantation by Intensified Heart Failure Therapy Optimization Supported by the Wearable Cardioverter/Defibrillator-The PROLONG Study.
    Duncker D; König T; Hohmann S; Bauersachs J; Veltmann C
    J Am Heart Assoc; 2017 Jan; 6(1):. PubMed ID: 28096098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wearable cardioverter-defibrillator use in patients perceived to be at high risk early post-myocardial infarction.
    Epstein AE; Abraham WT; Bianco NR; Kern KB; Mirro M; Rao SV; Rhee EK; Solomon SD; Szymkiewicz SJ
    J Am Coll Cardiol; 2013 Nov; 62(21):2000-2007. PubMed ID: 23916930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term use of the wearable cardioverter defibrillator in patients with explanted ICD.
    Kaspar G; Sanam K; Gholkar G; Bianco NR; Szymkiewicz S; Shah D
    Int J Cardiol; 2018 Dec; 272():179-184. PubMed ID: 30121177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wearable cardioverter defibrillator multicentre experience in a large cardiac surgery cohort at transient risk of sudden cardiac death.
    Kuehn C; Ruemke S; Rellecke P; Lichtenberg A; Joskowiak D; Hagl C; Hassan M; Leyh RG; Erler S; Garbade J; Eifert S; Grieshaber P; Boening A; Doenst T; Velichkov I; Madej T; Knaut M; Hain A; Burger H
    Eur J Cardiothorac Surg; 2022 May; 61(5):1031-1040. PubMed ID: 35174386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes during and after the use of the wearable cardioverter-defibrillator in a tertiary-care and a regional hospital in Switzerland.
    Kovacs B; Reek S; Saguner AM; Krasniqi N; Eriksson U; Duru F
    Swiss Med Wkly; 2019 Nov; 149():w20136. PubMed ID: 31707723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ECG as a risk stratification tool in patients with wearable cardioverter-defibrillator.
    Gassanov N; Mutallimov M; Caglayan E; Erdmann E; Er F
    J Cardiol; 2022 Dec; 80(6):573-577. PubMed ID: 35985868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Collaborative care for the wearable cardioverter defibrillator patient: Getting the patient and medical team "vested and active".
    Sears SF; Tripp C; Huber NL; Khan S; Nekkanti R; Burch AE; Pokorney SD
    J Cardiovasc Electrophysiol; 2020 Sep; 31(9):2509-2515. PubMed ID: 32757437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Keeping up to date: a current review of wearable cardioverter defibrillator use.
    Ashraf S; Ilyas S; Siddiqui F; Ando T; Shokr M; Panaich S; Briasoulis A; Afonso L; Khan M
    Acta Cardiol; 2020 Dec; 75(8):695-704. PubMed ID: 31687917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk for ventricular fibrillation in peripartum cardiomyopathy with severely reduced left ventricular function-value of the wearable cardioverter/defibrillator.
    Duncker D; Haghikia A; König T; Hohmann S; Gutleben KJ; Westenfeld R; Oswald H; Klein H; Bauersachs J; Hilfiker-Kleiner D; Veltmann C
    Eur J Heart Fail; 2014 Dec; 16(12):1331-6. PubMed ID: 25371320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The wearable cardioverter defibrillator - temporary protection against sudden cardiac death].
    Almqvist M; Mattsson G; Magnusson P
    Lakartidningen; 2019 Apr; 116():. PubMed ID: 31192401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.